These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4286330)

  • 41. Initiating influenza chemoprophylaxis with the first influenza case: a new institutional standard?
    Gravenstein S
    Clin Infect Dis; 2008 Jul; 47(1):53-5. PubMed ID: 18484877
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influenza prevention with 1-amino-adamantan-hydrochloride].
    Gerth HJ
    Med Welt; 1966 Jan; 1():14-8. PubMed ID: 5942359
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prevention of influenza and other acute respiratory diseases among the troops].
    Perepelkin VS
    Voen Med Zh; 1986 Nov; (11):32-4. PubMed ID: 3824975
    [No Abstract]   [Full Text] [Related]  

  • 45. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE; Peckinpaugh RO; Frazier WE; Griffin JP; Greenberg BH; Jackson GG
    Antimicrob Agents Chemother (Bethesda); 1965; 5():55-8. PubMed ID: 4286921
    [No Abstract]   [Full Text] [Related]  

  • 46. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH; Dudding BA; Russell PK; Buescher EL
    Am J Epidemiol; 1971 Aug; 94(2):142-6. PubMed ID: 4327997
    [No Abstract]   [Full Text] [Related]  

  • 47. Adenovirus vaccines in military recruit populations: a cost-benefit analysis.
    Collis PB; Dudding BA; Winter PE; Russell PK; Buescher EL
    J Infect Dis; 1973 Dec; 128(6):745-52. PubMed ID: 4358121
    [No Abstract]   [Full Text] [Related]  

  • 48. The present and future of specific prophylaxis of influenza and other acute viral respiratory diseases.
    Zykov MP; Smorodintsev AA; Alexandrova GI; Zlydnikov DM; Golubev DB; Shadrin AS
    Am Rev Respir Dis; 1974 Nov; 110(5):537-41. PubMed ID: 4611289
    [No Abstract]   [Full Text] [Related]  

  • 49. A design for the evaluation of antiviral drugs in human influenza.
    Bloomfield SS; Gaffney TE; Schiff GM
    Am J Epidemiol; 1970 Jun; 91(6):568-74. PubMed ID: 4910877
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH; Buescher EL; Bancroft WH; Russell PK
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract]   [Full Text] [Related]  

  • 51. Control of acute mycoplasmal and viral respiratory tract disease.
    Chanock RM
    Science; 1970 Jul; 169(3942):248-56. PubMed ID: 4317229
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of a "mixed bacterial vaccine" in prophylaxis of acute respiratory infections: possible role of interferon.
    Rytel MW; Ferstenfeld JE; Rose HD; Balay J; Pierce WE; Lynch KL
    Am J Epidemiol; 1974 May; 99(5):347-59. PubMed ID: 4151096
    [No Abstract]   [Full Text] [Related]  

  • 53. A perspective from controlled investigations of chemotherapy for viral respiratory infections.
    Jackson GG
    J Infect Dis; 1976 Jun; 133 Suppl(Suppl 2):A83-92. PubMed ID: 778309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent experiences with live adenovirus vaccines in navy recruits.
    Rosenbaum MJ; Edwards EA; Hoeffler DF CAPT
    Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH; Grossman RA; Bartelloni PJ; Segal HE; Dudding BA; Russell PK; Buescher EL
    J Infect Dis; 1971 Aug; 124(2):148-54. PubMed ID: 4330997
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971.
    Dudding BA; Top FH; Winter PE; Buescher EL; Lamson TH; Leibovitz A
    Am J Epidemiol; 1973 Mar; 97(3):187-98. PubMed ID: 4348245
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparative study of the epidemiological efficacy of specific and nonspecific influenza preventive agents].
    Shvetsova EG; Malysheva AM; Karapats NM; Oleĭnikova EV; Vasil'eva RI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):47-51. PubMed ID: 4133821
    [No Abstract]   [Full Text] [Related]  

  • 58. Amantadine hydrochloride as a prophylactic in respiratory infections. A double-blind investigation of its clinical use and serology.
    Callmander E; Hellgren L
    J Clin Pharmacol J New Drugs; 1968; 8(3):186-9. PubMed ID: 4872082
    [No Abstract]   [Full Text] [Related]  

  • 59. [Economic losses because of influenza and other respiratory infections and possibilities of their reduction].
    Shevchenko LF; Siniak KM; Sazhok RA; Stepanchuk VA; Ryzhevskaia NI
    Vrach Delo; 1974 Nov; 0(11):154-7. PubMed ID: 4215227
    [No Abstract]   [Full Text] [Related]  

  • 60. Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.
    Pierce WE; Rosenbaum MJ; Edwards EA; Peckinpaugh RO; Jackson GG
    Am J Epidemiol; 1968 Jan; 87(1):237-46. PubMed ID: 4295428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.